<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01329731</url>
  </required_header>
  <id_info>
    <org_study_id>GASAS-1002X</org_study_id>
    <secondary_id>2010-020538-24</secondary_id>
    <nct_id>NCT01329731</nct_id>
  </id_info>
  <brief_title>Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients</brief_title>
  <official_title>White Spot Lesion Development in Post-orthodontic Patients Following Weekly Application of a 1.25% Fluoride Gel Compared to Placebo Over 6 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gaba International AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PD Dr. Christian Heumann</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gaba International AG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to monitor the effect of intraoral topical high fluoride application
      on the development of white spot lesions (WSL) after orthodontic treatment with multibracket
      appliances and to compare it to a placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WSL-size change</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in size of white spot lesions (WSL) at 12 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>WSL-size change</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>Changes in size of WSL over study time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WSL-brightness change</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>Changes in WSL brightness value (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WSL index on all upper front teeth</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>Modified white spot lesion index (Gorelick et al. 1982):
0: no white spot formation
slight white spot formation, thin rim
excessive white spot formation, thicker bands
white spot formation with cavitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caries activity</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>Caries activity index (LAA) according to the ICDAS II (Ekstrand et al. 2007)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index (Silness and Löe 1964)on all upper front teeth</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>The grades will be assessed visually on all upper front teeth using a standard dental probe.
(0) no plaque on inspection and probing
thin plaque film on gingival margin, detectable only on probing
moderate plaque film along the gingival margin, visually detectable even without probing
a lot of plaque along the gingival margin, filling the interdental spaces</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gingival bleeding index on all upper front teeth</measure>
    <time_frame>Baseline up to 24 weeks</time_frame>
    <description>Gingival bleeding index (Ainamo and Bay 1975). The following scores will be used:
(0) no bleeding
(1) bleeding occurs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DMFT index: Dental health of all teeth</measure>
    <time_frame>Baseline, 24 weeks</time_frame>
    <description>DMFT index according to Klein et al. (1938): Dental health of all teeth will be assessed with respect to decay (D), missing (M) or filling (F). The DMFT-Index will be calculated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Tooth; Lesion, White Spot Lesions</condition>
  <arm_group>
    <arm_group_label>Test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.25% fluoride (elmex® gelée)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0% fluoride (negative control)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>elmex® gelée</intervention_name>
    <description>1.25% fluoride (elmex® gelée) Dosage: Weekly brushing with 0.5g of respective gel Route: Intraoral topical</description>
    <arm_group_label>Test</arm_group_label>
    <other_name>elmex® gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>negative control (placebo)</intervention_name>
    <description>0% fluoride (negative control) Dosage: Weekly brushing with 0.5g Route: Intraoral topical</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Healthy volunteers (≥11 years) scheduled for bracket removal

          -  ≥ 1 WSL with a modified score 1 or 2 (Gorelick et al. 1982) on UFT at debonding

        Exclusion Criteria:

          -  Known hypersensitivity or allergy to study products and standard toothpaste
             ingredients and/or dental material used in the present study

          -  Known hypersensitivity or allergy to placebo gel ingredients

          -  Alterations in the teeth's enamel, e.g. hypoplasia, fluorosis

          -  Any illness/condition potentially affecting the study outcome at investigator's
             discretion

          -  Known pregnancy or breast feeding during the course of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Poliklinik für Kieferorthopädie, Justus-Liebig-Universität Giessen</name>
      <address>
        <city>Giessen</city>
        <zip>D-35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2011</study_first_submitted>
  <study_first_submitted_qc>April 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2011</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>white spot lesion</keyword>
  <keyword>initial caries</keyword>
  <keyword>fluoride</keyword>
  <keyword>amine fluoride</keyword>
  <keyword>orthodontics</keyword>
  <keyword>remineralization</keyword>
  <keyword>brackets</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Olaflur</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

